T-group (topology)
231.1.2 DmpA/ArgJ
Ligands and drugs
404
Member domains
97
with ligand contacts (≤ 4 Å)
24.0% of members
90
with DrugDomain annotations
22.3% of members
68
with a DrugBank compound
16.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 231.1.2 belongs to X-group 231 MocoBD/DmpA-related, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00129 | ORN | Ornithine | 4 |
| DB00415 | AIC | Ampicillin | 4 |
| DB07347 | AES | 4-(2-Aminoethyl)Benzenesulfonyl Fluoride | 4 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB03793 | BEZ | Benzoic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 14 |
| CL | CHLORIDE ION | 10 |
| CAmetal | CALCIUM ION | 8 |
| AES | 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE | 4 |
| AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLICACID | 4 |
| OAE | (2S,4S)-2-[(R)-{[(2R)-2-amino-2-phenylacetyl]amino}(carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 4 |
| ORN | L-ornithine | 4 |
| GLU | GLUTAMIC ACID | 3 |
| EMC | ETHYL MERCURY ION | 2 |
| NDV | (2S,4S)-2-[(1R)-1-{[(2R)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 2 |
| TXI | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide | 2 |
| BEZ | BENZOIC ACID | 1 |
| UNL | Unknown ligand | 1 |